AnalystsAlex NowarkAlex Nowark's Stock Forecasts
AnalystsAlex Nowark
Analyst Ranking
Top 9%
#475 out of 5290 analysts
Average Return
+270.41%
Win Rate
54%7 out of 13
Risk vs Reward
Poor
Good
Alex Nowark's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Exact Sciences CorpEXAS | +3,230.52% | $56.00 | $1,865.09 | 2025-09-10 - 2026-03-24 | Buy |
Guardant Health IncGH | +152.15% | $18.10 | $45.64 | 2024-04-23 - 2025-04-23 | Buy |
Exact Sciences CorpEXAS | +78.88% | $47.59 | $85.13 | 2022-08-02 - 2023-08-02 | Buy |
Neogenomics IncNEO | +75.00% | $29.48 | $51.59 | 2020-03-01 - 2021-03-02 | Buy |
Guardant Health IncGH | +66.47% | $30.27 | $50.39 | 2024-08-07 - 2025-08-07 | Buy |
Alex Nowark Analyst Color
Get additional color on Alex Nowark's coverage of popular stocks
Alex Nowark's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Adagio Medical Holdings IncADGM | 1 | Strong Buy | $3.00 | +300.00% | Initiates Coverage On | a day ago |
Microbot Medical IncMBOT | 1 | Strong Buy | $4.00 | +103.05% | Initiates Coverage On | a day ago |
Ss Innovations International IncSSII | 1 | Strong Buy | $7.00 | +62.41% | Initiates Coverage On | a day ago |
Exact Sciences CorpEXAS | 4 | Buy | $85.00 | -95.44% | Maintains | 9 months ago |
Guardant Health IncGH | 3 | Buy | $37.00 | N/A | Maintains | 2 years ago |
Neogenomics IncNEO | 2 | Buy | $26.00 | N/A | Assumes | 2 years ago |
Smiledirectclub IncSDCCQ | 2 | Hold | N/A | N/A | Upgrades | 4 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.